Participant flow16

How many started, completed or left each group, period by period.

1 to 16 of 16

Period	Milestone	Group	Participants
Overall Study	STARTED	MFNS 200 μg + Loratadine 10 mg	169
Overall Study	STARTED	MFNS 200 μg	176
Overall Study	STARTED	Loratadine 10 mg	182
Overall Study	STARTED	Placebo	177
Overall Study	Treated	MFNS 200 μg + Loratadine 10 mg	169
Overall Study	Treated	MFNS 200 μg	176
Overall Study	Treated	Loratadine 10 mg	181
Overall Study	Treated	Placebo	176
Overall Study	COMPLETED	MFNS 200 μg + Loratadine 10 mg	166
Overall Study	COMPLETED	MFNS 200 μg	167
Overall Study	COMPLETED	Loratadine 10 mg	174
Overall Study	COMPLETED	Placebo	158
Overall Study	NOT COMPLETED	MFNS 200 μg + Loratadine 10 mg	3
Overall Study	NOT COMPLETED	MFNS 200 μg	9
Overall Study	NOT COMPLETED	Loratadine 10 mg	8
Overall Study	NOT COMPLETED	Placebo	19

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03855228/flow